RaySearch receives 510(k) clearance for RayStation

RaySearch receives 510(k) clearance for RayStation

RaySearch Laboratories AB (publ) has received FDA 510(k) clearance for its
RayStation® treatment planning system.

RayStation® is RaySearch's proprietary complete treatment planning system that
integrates all RaySearch's advanced treatment planning solutions into one
flexible system. It includes functionality such as RaySearch's market-leading
algorithms for IMRT and VMAT optimization, highly accurate dose engines for both
photon and proton therapy and will have full support for 4D adaptive radiation
therapy. The system is built on the latest software architecture and has a
graphical user interface offering state-of-the-art usability.

RaySearch's business model is based on selling software modules through
partnerships with leading medical technology companies. RaySearch's modules are
integrated into the partners' systems and the partners have all contacts with
the clinics. As a complement to this partner-based business model, RayStation®
offers the possibility to collaborate directly with a few selected leading
research-intensive clinics. This type of collaboration gives RaySearch the
freedom to develop innovative solutions directly in a clinical environment,
which is a prerequisite for securing the company's long-term position as a
leading supplier of advanced radiation therapy software.

In June 2009 a first agreement was signed in Europe with the German clinic WPE
where RayStation® is planned to be clinically operational in 2010. Receiving
510(k) clearance means that RaySearch can now market RayStation® in the US and
enter similar collaboration agreements in that region too.

”The fact that we now have our own treatment planning system with FDA clearance
is a milestone of strategic importance,” says Johan Löf, CEO of RaySearch. ”We
have no intentions to go out broadly to a large number of clinics so this does
not mean that we alter our business model in a significant way. However,
RayStation® gives us the possibility to develop the solutions of the future
together with some of the world's leading clinics, which is extremely important
for us over the long term,” concludes Johan Löf. 
 
ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch's
products are sold through license agreements with leading partners, such as
Philips, Varian, Siemens, Nucletron, IBA Dosimetry and TomoTherapy. To date, 15
products have been launched and RaySearch's software is used in about 1,500
clinics in more than 30 countries. In addition, existing license agreements
cover more than 15 other products that are scheduled to be launched in the
coming years. RaySearch was founded in 2000 as a spin-off from Karolinska
Institutet in Stockholm and the company is listed in the Small Cap segment of
NASDAQ OMX Nordic Exchange Stockholm.

For more information about RaySearch, visit www.raysearchlabs.com.

FOR FURTHER INFORMATION, PLEASE CONTACT:
Johan Löf, President and CEO
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com